Tanezumab Clinical Trials Sponsored by Pfizer

2011-05-25: We appreciate your patience while we work on this page.

Consent Forms

Informed Consent Protocol No. A4091016 A Phase 3 Multicenter Randomized Long Term Study of the Safety of Tanezumab in Patients with Osteoarthritis of the Knee or Hip 2009-09-10: http://www.circare.org/consents/a4091016_20090910.pdf

Informed Consent Protocol No. A4091016 A Phase 3 Multicenter Randomized Long Term Study of the Safety of Tanezumab in Patients with Osteoarthritis of the Knee or Hip 2010-07-26: http://www.circare.org/consents/a4091016_20100726.pdf

Clinical Trials of Tanezumab

Background Information on Tanezumab

News Stories on Tanezumab

UPDATE 2-Pfizer halts clinical trials of arthritis drug. Bill Berkrot. Reuters 2010-06-23: http://www.reuters.com/article/2010/06/23/pfizer-arthritis-idUSN2320755920100623

Pfizer Press Releases on Tanezumab

Tanezumab Information in Pfizer SEC Filings

top

If you find the information on this page helpful please support CIRCARE with a tax-deductible contribution today. Because CIRCARE doesn't accept funds from pharmaceutical or medical device manufacturers, we depend on contributions from individuals like you to help us advocate for meaningful protection of human subjects in research. Find out more on our Support page

---